You must be signed in to set price alerts.
Pinned straw:
For those of you interested in Donenemab by Eli Lilly: see below. Certainly looks like a better treatment option as less frequent dosing.
https://endpts.com/lillys-alzheimers-drug-donanemab-succeeds-in-phase-iii-trial/
Great news and a positive reaction by the market too.
The story about the drug was on 7 news last night. Should be a good day today but such a topsy-turvy ride holding this!
There is a trade pending processing for this company.
Trades cannot be saved or cancelled while they are pending-processing.